Kurt Herrenknecht
About Kurt Herrenknecht
Kurt Herrenknecht serves as the Director of Business Development for Europe at Canopy Biosciences, focusing on pre-clinical and clinical R&D in immuno-oncology. He holds a doctorate in biology and has extensive experience in business development within the biotechnology and pharmaceutical sectors.
Current Role at Canopy Biosciences
Kurt Herrenknecht serves as the Director of Business Development for Europe at Canopy Biosciences since 2020. Based in Hamburg, he focuses on expanding the company's presence in the European market. His role involves fostering strategic partnerships and enhancing technology applications in the biotechnology sector. Herrenknecht's work is pivotal in driving growth and innovation within the organization.
Education and Expertise
Kurt Herrenknecht holds a Dr. rer. nat. from the Max-Planck-Institute of Immunobiology, where he studied Biology from 1988 to 1992. He also earned a Diplom Biologe Univ from The Julius Maximilians University of Würzburg, studying Biology from 1982 to 1988. His academic background provides a strong foundation for his expertise in multi-omics technologies, including NanoString, RNASeq, GeoMX DSP, and ChipCytometry, which he employs for high-plex proteomics investigations.
Previous Experience in Business Development
Prior to his current position, Kurt Herrenknecht held several roles in business development across various organizations. He was a Strategic Account Manager at Unchained Labs from 2016 to 2018 and served as Director of Business Development at Freeslate Inc. from 2014 to 2016, both in the San Francisco Bay Area. Additionally, he worked at Proteros biostructures GmbH as Director of Business Development from 2009 to 2011 in Munich, Germany.
Leadership Roles in Biotechnology
Kurt Herrenknecht has held significant leadership positions in the biotechnology sector. At Evotec AG, he worked as Group Leader, Laboratory Head, and Project Manager from 1999 to 2003 in Hamburg, Germany. He also served as Business Development/Collaborations Manager at PerkinElmer Cellular Technologies Germany GmbH from 2003 to 2008. These roles contributed to his extensive experience in managing R&D programs and clinical trials, particularly in immuno-oncology and immune biomarker fields.
Webinars and Strategic Partnerships
Kurt Herrenknecht offers one-to-one webinars aimed at discussing strategic partnerships and technology applications within the biotechnology and pharmaceutical sectors. These webinars serve as a platform for knowledge sharing and collaboration, reflecting his commitment to advancing the industry through strategic engagement and innovation.